Skip to content

Bratton Capital Management, L.P.

Follow

13F filer, CIK 1723787, FORT WORTH, TX

Bratton Capital Management, L.P. reported $40,813,585 across 1 holding for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-11.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001315863-26-000581

Period
2026-06-30
Reported value
$40.8M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Part of the filer group Bratton Capital Management, L.P.

  • Bratton Capital Inc.
  • Bratton Family Partners L.P.
  • MonoLine Partners, L.P.
  • MonoLine RX III, L.P.
  • MonoLine RX II, L.P.
  • MonoLine RX, L.P.
  • MonoSol Rx Genpar, L.P.
  • BRATTON DOUGLAS K
How groups are built

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001315863-26-000581, largest first. % of portfolio is the value over $40,813,585, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 9,810,958 shares; 2024Q4: 9,810,958 shares; 2025Q1: 9,810,958 shares; 2025Q2: 9,810,958 shares; 2025Q3: 9,810,958 shares; 2025Q4: 9,810,958 shares; 2026Q1: 9,810,958 shares; 2026Q2: 9,810,958 shares 9,810,958$40.8M100%02026-10-07, 13G/A: 691,873 shares, 0.6% of the class, 13G/A filed 2026-10-07 Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001315863-26-000581 base2026-08-11acceptance time not in the bulk data set